Oscar Health, Inc.
OSCR
$15.65
$1.5010.60%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.06B | 9.16B | 8.20B | 7.21B | 6.51B |
| Total Other Revenue | 19.27M | 20.58M | 21.49M | 22.13M | 21.98M |
| Total Revenue | 10.08B | 9.18B | 8.22B | 7.23B | 6.54B |
| Cost of Revenue | 8.04B | 7.33B | 6.47B | 5.63B | 5.11B |
| Gross Profit | 2.04B | 1.84B | 1.74B | 1.60B | 1.43B |
| SG&A Expenses | 1.84B | 1.76B | 1.65B | 1.52B | 1.42B |
| Depreciation & Amortization | 31.06M | 32.15M | 30.65M | 32.35M | 33.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.91B | 9.12B | 8.16B | 7.18B | 6.56B |
| Operating Income | 168.83M | 57.27M | 59.52M | 49.65M | -24.69M |
| Income Before Tax | 143.16M | 33.43M | 36.47M | 24.00M | -51.22M |
| Income Tax Expenses | 19.01M | 7.31M | 6.90M | 5.74M | 2.27M |
| Earnings from Continuing Operations | 124.15 | 26.12 | 29.57 | 18.25 | -53.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -810.00K | -689.00K | -619.00K | -106.00K | -104.00K |
| Net Income | 123.34M | 25.43M | 28.95M | 18.15M | -53.59M |
| EBIT | 168.83M | 57.27M | 59.52M | 49.65M | -24.69M |
| EBITDA | 199.89M | 89.41M | 90.17M | 81.99M | 8.87M |
| EPS Basic | 0.49 | 0.16 | 0.12 | 0.05 | -0.26 |
| Normalized Basic EPS | 0.35 | 0.12 | 0.09 | 0.05 | -0.16 |
| EPS Diluted | 0.21 | -0.08 | -0.06 | -0.13 | -0.40 |
| Normalized Diluted EPS | 0.19 | -0.02 | -0.05 | -0.09 | -0.26 |
| Average Basic Shares Outstanding | 981.27M | 961.43M | 940.30M | 920.30M | 901.02M |
| Average Diluted Shares Outstanding | 1.10B | 1.09B | 1.07B | 1.05B | 963.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |